Skip to main content
. 2019 Dec 12;10(2):109–122. doi: 10.1016/j.jpha.2019.12.003

Table 2.

High performance liquid chromatography (HPLC) technique coupled with hollow fiber based extraction techniques for pharmaceutical drugs.

Analyte Preconcentration/Separation method Membrane / SLM composition Real applications LODa EF/PFb LRc Instrumental tec. Ref.
Atenolol, betaxolol, propranolol Microfluidic EME NPOE + DEHP + TEHP Urine, plasma 4–10 μg/L 10–850 μg/L HPLC-UV [66]
Amoxicillin, nicotinic acid, hippuric acid, salicylic acid, anthranilic acid, ketoprofen, naproxen, ibuprofen EME Chitosan membrane = 60% chitosan + 40% Aliquat®336 / 1-octanol Urine HPLC-DAD [67]
Epinephrine, norepinephrine dopamine Complexation mediate-EME, EME TFPBA + DEHPi Urine 1.8–5 μg/L 2.2–6 HPLC-UV-MS [68]
Tetracycline, chlortetracycline, doxycycline, oxytetracycline HF-DLLME Aliquat-336 + 1-octanol Milk 0.95–3.6 μg/L HPLC-UV [69]
2-methyl hippuric acid, 3- methyl hippuric acid, 4- methyl hippuric acid HFLPME 1-octanol Urine 2–3 μg/L 210–312 10–50,000 μg/L HPLC-UV [70]
Hippuric acid, mandelic acid HF-LPME 1-octanol + TBP Urine 0.007–0.009 μg/mL 172–195 0.02–20 mg/L HPLC-UV [71]
54 care products + pharmaceutical drugs HFLSPME 1-octanol + toluene Fish, water 0.31–1.61 μg/kg 0.11–12.83 HPLC-MS [72]
Pramipexole EME RGO + NPOE Water and urine samples 0.04 and 0.14 ng/mL 301 and 265 0.13–1000 ng/mL HPLC-UV [73]
Haloperidol, loperamide, methadone, nortriptyline, pethidine EME NPOE, TBP HPLC-UV [74]
Codeine, naloxone, naltrexone PEME DEHP + NPOE Plasma, urine 2–10 μg/L 10.–500 μg/L HPLC-UV [75]
Rivastigmine, verapamil, amlodipine, morphine EME Agarose gel as SLM Wastewater 1.5–1.8 ng/mL 5–1000 ng/mL HPLC-UV [76]
Nicotinic acid, amoxicillin, hippuric acid, salicylic acid EME Acrylic nanofibers membrane /Aliquat®336 + 1-octanol Urine samples 112–402.3 μg/L 173.3–4000 μg/L HPLC-DAD [77]
Ephedrine, clonidine On chip-EME DEHP + NPOE Urine, plasma <11 μg/L 12–19 10–500 μg/L HPLC-UV [78]
Imipramine, amitriptyline, chlorpromazine μEME Agarose film as membrane / 1-hexyl-3-methylimidazolium hexafluorophosphate River and tap water 0.1–0.4 μg/L 110–150 1.0–1000 μg/L HPLC-UV [79]
Ibuprofen, sodium diclofenac EME C60 fullerene + 1-octanol Urine 9–10 ng/mL 166–188 15–500 ng/mL HPLC-UV [80]
Ketoprofen, diclofenac, ibuprofen, mefenamic acid EME Agarose film / 1-octanol River and tap water 0.14–0.42 62–86 0.5–500 HPLC-UV [81]
Verapamil, Haloperidol, rivastigmine, clomipramine CF-EME 2-ethylhexanol Wastewater and urine samples 2.4 ng/mL >44 8.0–500 ng/mL HPLC-UV [82]
Various drugs and other contaminants HFLPME 1-octanol Water samples 1.09–98.15 ng/L 6–4177 UPLC-MS [83]
Ketoprofen, ibuprofen, naproxen, diclofenac HFLPME DHE Urine 1.6–4.3 μg/L 43.2–96.8 5–500 μg/L HPLC-DAD [84]
Propranolol, carvedilol, verapamil, amlodipine HFLPME Choline chloride + 1-phenylethanol Urine, plasma, pharmaceutical wastewater 0.3–0.8 ng/mL 110–135 0.8–500 ng/mL HPLC-UV [85]
Salicylic acid, ketoprofen, naproxen, ibuprofen, anthranilic acid, nicotinic acid, amoxicillin, hippuric acid EME PIM = 29% CTA + 71% Aliquat®336 / 1-octanol Urine samples 18–100 μg/L 61–500 μg/L HPLC-DAD [86]
Pseudoephedrine, lidocaine, propranolol EME Polyacrylamide gel as membrane Breast milk, wastewater 0.3–6.0 ng/mL 23.1–29.5 1–200 ng/mL HPLC-UV [87]
Zolpidem EME 2-ethylhexanol Plasma, urine 3 ng/mL 75 10–1000 ng/mL HPLC-UV [88]
Indoprofen, ketoprofen, naproxen, ibuprofen EME 1-octanol Urine 0.20–0.27 μg/mL 0.68–8.4 μg/mL HPLC-UV [89]
Valproic acid EME 1-octanol Plasma 0.5 μg/mL >125 0.5–10 μg/mL HPLC-UV [90]
Amlodipine, verapamil, clomipramine EME 2-ethylhexanol Wastewater, plasma, urine 3.3–5 μg/L 98.89–130.3 10–2000 μg/L HPLC-UV [91]
Metaraminol, benzamidine, sotalol, ephedrine, trimethoprim, pethidine hydrochloride, quetiapine, haloperidol, nortriptyline hydrochloride, methadone hydrochloride, loperamide hydrochloride EME Phthalate- and nitrile-based organic solvents Plasma HPLC-UV [92]
Five fluoroquinolones and four parabens μEME / LPME 1-octanol Urine 16–75 μg/L 0.25-10 and 0.06–5 μg/mL respectively HPLC-UV [93]
Diclofenac HFLPME 1-octanol Urine and plasma 2.8 ng/mL 170 50–2000 ng/mL HPLC-UV [94]
Exemestane, letrozole, paclitaxel HFLPME n-dodecane + TOPO Urine 0.3–0.6 μg/L 152–411 0.9–200 μg/L HPLC-UV [95]
Omeprazole, pantoprazole, lansoprazole HFLPME 1-octanol Plasma 0.2 μg/mL 1.5–13 0.2–2.0 μg/mL HPLC-DAD [96]
Phenazopyridine HFSLPME 1-octanol Urine 0.02 μg/L 0.01–10 μg/L HPLC-DAD [97]
Different sulfonamides HFPLME 1-octanol Environmental water 3.1–11.2 ng/L 14–60 0.05–5 μg/L UHPLC-FLD [98]
Thiabendazole HFM-MI-MSPE Orange or lemon peel samples 0.004 mg/kg 0.02–2 mg/L HPLC-DAD [99]
Leuprolide, triptorelin EME 1-octanol + 2-ethyl hexanol + DEHP Rabbit plasma 0.15 ng/mL 0.5–1000 ng/mL HPLC-PAD [100]
Salicylic acid, naproxen, ketoprofen, diclofenac, ibuprofen EME 1-octanol Urine 0.1–1.5 ng/mL 85–133 0.5–750 ng/mL HPLC-DAD/FLD [101]
Naproxen, verapamil EME 1-octanol, 2-ethylhexanol Lemon juice, soft drinks HPLC-UV [102]
Verapamil, riluzole EME Mixture of 2-ethyl hexanol and 1-otanol Urine, wastewater 1.5–2.5 ng/mL 123.6–146.6 1.5–500 ng/mL HPLC-UV [103]
Barbital, phenobarbital, pentobarbital FMLPME 2-nonanone Blood, urine, liver 0.6–10 ng/g 5–2500 ng/g HPLC-MS [104]
Ciprofloxacin On chip PEME 1-octanol Blood 1 μg/L 88 2–500 μg/L HPLC-UV [105]
Nalmefene, diclofenac On chip-EME NPOE + DEHP and 1-octanol Urine 3–4 μg/L 17–19 9.0–500 μg/L HPLC-UV [106]
Ezetimibe, simvastatin CA–HF–SLPME Cetyl alcohol + 1-octanol Plasma, urine 0.363–0.49 μg/L 0.3363–25 μg/L HPLC-DAD [107]
Fosdanofloxacin, norfloxacin, enrofloxacin, ciprofloxacin MIP-HFME Toluene Environmental water, urine 0.1–10 μg/L HPLC-MS [108]
Raloxifene, ethinylestradiol HFLPME 1-octanol + CTAB Pharmaceutical waste water 5–10 μg/L 53–86 20–5000 μg/L HPLC-UV [109]

HFDLLME: Hollow fiber dispersive liquid-liquid microextraction, HFLSPME: Hollow fiber liquid solid phase microextraction, PEME: Pulsed electromembrane extraction, CF-EME: Continuous-flow electromembrane extraction, LPME: Liquid phase microextraction, HFM-MI-MSPE: Hollow fiber membrane-molecular imprinted-micro solid phase microextraction, FMLPE: Flat membrane based liquid phase microextraction, CA–HF–SLPME: Cetyl-alcohol-reinforced hollow fiber solid/ liquid phase microextraction, MIP-HFME: Molecular imprinted polymer hollow fiber microextraction, DEHPi: Bis(2-ethylhexyl) phosphite, TFPBA: 4-(trifluoromethyl)phenylboronic acid, RGO: Reduced graphene oxide, TBP: Tributyl phosphate, DHE: Dihexyl ether, PIM: Polymer inclusion membrane, TOPO: Trioctylphosphine oxide HPLC-UV: High performance liquid chromatography with UV detector, HPLC-MS: High performance liquid chromatography with mass spectrometry, HPLC-DAD-FLD: High performance liquid chromatography with diode array detector and fluorescence detector, HPLC-UV-MS: High performance liquid chromatography with UV detector and mass spectrometry, UHPLC-MS: Ultra high performance liquid chromatography with mass spectrometry, HPLC-DAD: High performance liquid chromatography with diode array detector, Fluorometer/RGB/ HPLC-UV: Fluorometer/ Red Green Blue analysis/ High performance liquid chromatography with UV detector.

a

Limit of detection.

b

Enrichment factor/Pre-concentration factor.

c

Linear range.